Clinical Trial Update: Exenatide for Myocardial Protection During Reperfusion Study [Phase 2]

View source ↗

Summary

Phase 2 study update evaluating Exenatide for myocardial protection during reperfusion in myocardial infarction; the trial status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• EXENATIDE (EXENATIDE)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Myocardial Infarction | Phase 2 | Status: UNKNOWN